Oxramet Xr 10/500 MG Tablet 7

Oxramet XR 10mg/500mg Tablet is a drug that combines two medicines to treat type 2 diabetes. It aids in the management of elevated blood sugar levels associated with diabetes. This lowers the risk of significant diabetes complications and helps to prevent heart disease. Oxramet XR 10mg/500mg Tablet can be taken with or without meals at any time of day, although it is best if you take it at the same time each day. Your doctor will determine the dosage. Do not stop taking it without first consulting your physician. If you do, your blood sugar levels may rise, putting you at risk for significant consequences such as kidney damage and blindness. Oxramet XR 10mg/500mg Tablet  is simply one component of a comprehensive treatment plan that includes a balanced diet, regular exercise, and weight loss as directed by your doctor. Sore throat, nasal congestion, runny nose, headache, nausea, vomiting, and diarrhoea are the most common adverse effects of Oxramet XR 10mg/500mg Tablet. Dehydration can be avoided by drinking enough of fluids while using it. Fungal infections in the vaginal area can occur in some people. This can be avoided by practising excellent hygiene. If you have any kidney or liver problems, a urinary tract infection, or are taking water pills, tell your doctor before using Oxramet XR 10mg/500mg Tablet (diuretics). Women who are pregnant or breastfeeding should also seek medical advice before taking it. Avoid drinking too much alcohol while taking it, as this may raise your risk of having negative effects. While using this medicine, keep a close eye on your blood sugar levels. Use of Oxramet XR 10mg/500mg Tablet during pregnancy may be dangerous. Animal research have demonstrated negative effects on the growing foetus, despite the lack of human studies. Before prescribing it to you, your doctor will consider the advantages as well as any potential hazards. Please seek medical advice. Using Oxramet XR 10mg/500mg Tablet during breastfeeding is generally not a good idea. The medicine may transfer into breastmilk and harm the newborn, according to limited human research.